D3-Pharmacy Aps: Financial statements 2023
CVR: 71087611
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
D3-Pharmacy Aps (CVR 71087611) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -10,995 and a net result of DKK -5,594 compared with DKK -17,788 the year before. Equity in the 2023 report amounted to DKK 543,318. The solvency ratio was 99.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -10,995
- Profit/Loss
- DKK -5,594
- Equity
- DKK 543,318
- Total Assets
- DKK 545,569
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -11 t. | -6 t. | 543 t. | 1 |
| 2022 | - | -10 t. | -18 t. | 549 t. | 1 |
| 2021 | - | -3 t. | -7 t. | 567 t. | 1 |
| 2020 | - | -8 t. | -14 t. | 574 t. | 1 |
| 2019 | - | -8 t. | -14 t. | 588 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
D3-Pharmacy Aps has published its annual report for 2022. Gross profit came to DKK -10,365, and the net result was DKK -17,788.
About D3-Pharmacy Aps
D3-Pharmacy Aps is a Danish company of the type Anpartsselskab based in Svenstrup J, founded in 1982. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Finn Jørgen Jensen. The company is owned by Finn Jørgen Jensen. According to the 2023 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,710 and a net result of DKK -4,037 compared with DKK -13,135 the year before. Equity in the 2025 report amounted to DKK 526,147.